Nonnutritional Environmental Factors Associated with Celiac Disease: The Infectome

Infection and Autoimmunity

Volumn , Issue , 2015, Pages 829-837

  Lerner, Aaron ^a   Reif, Shimon ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Autoimmunity; Celiac disease; Environment; Infection; Infectome

Indexed keywords

EID: 85010315030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-63269-2.00051-9     Document Type: Chapter

References (58)

1. Lerner A., Blank M., Shoenfeld Y. Celiac disease and autoimmunity. Isr J Med Sci 1996, 32:33-36.
2. Reif S., Lerner A. Celiac disease and infection. Infections and Autoimmunity 2004, 689-692. Elsevier B.V., Amsterdam. Y. Shoenfeld, N. Rose (Eds.).
3. Reif S., Lerner A. Tissue transglutaminase-the key player in celiac disease: a review. Autoimm Rev 2004, 3:40-45.
4. Shamir R., Eliakim R., Lahat N., Sobel E., Lerner A. ELISA assay of anti endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J 2002, 4:594-596.
5. Rozenberg O., Lerner A., Pacht A., Grinberg M., Reginashvili D., Henig C., et al. A novel algorithm for childhood celiac disease serological diagnosis based upon intestinal biopsies. Crit Rev Allerg Immunol 2010, 42:331-341.
6. Lerner A. New Therapeutic Strategies for Celiac Disease. Autoimmun Rev 2010, 9:144-147.
7. Lerner A. Factors affecting the clinical presentation and time diagnosis of celiac disease: the Jerusalem and the West Bank-Gaza experience (editorial). Isr J Med Sci 1994, 30:294-295.
8. Branski D., Ashkenazy A., Frier S., Lerner A., et al. Extra intestinal manifestation and associated disorders of celiac disease. Gluten-Sensitive Enteropathy From Gastrointest Res 1992, 164-175. Karger, Basel. D. Branski, P. Rozen, M.F. Kaganoff (Eds.).
9. Zelnik N., Pacht A., Obeid R., Lerner A. Range of neurological disorders in patients with celiac disease. Pediatrics 2004, 113:1672-1676.
10. Lerner A., Makhoul B. Neurological manifestations of celiac disease in children and adults. Europ Neurolog J 2012, 4:15-20.
11. Hartman C., Hino B., Lerner A., Eshach-Adiv O., Berkovitz D., Shaoul R., et al. Bone quantitative ultrasound and bone mineral density in children with celiac disease. J Pediatr Gastroenterol Nutr 2004, 39:504-510.
12. Lerner A., Shapira Y., Agmon-Levin N., Pacht A., Ben-Ami Shor D., López Hoyos M., et al. The clinical significance of 25OH-vitamin D status in celiac disease. Crit Rev Allerg Immunol 2012, 42:322-330.
13. Lerner A., Agmon-Levin N., Shapira Y., Gilburd B., Reuter S., Lavi L., et al. The thrombophylic network of autoantibodies in celiac disease. BMJ Medicine 2013, 11:89-95.
14. Lahat N., Shapiro S., Karban A., Gerstein R., Kinarty A., Lerner A. Cytokine profile in celiac disease. Scand J Immunol 1999, 49:441-446.
15. Shaoul R., Lerner A. Associated authoantibodies in celiac disease. Autoimmun Rev 2007, 6:559-565.
16. Bogdanos D.P., Smyk D.S., Invernizzi P., Rigopoulou R.I., Blank M., Sakkas L., et al. Tracing environmental markers of autoimmunity: introducing the infectome. Immunol Res 2013, 56:220-240.
17. Kivity S., Agmon-levin N., Blank M., Shoenfeld Y. Infections and autoimmunity-friends or foes?. Trends Immunol 2009, 30:409-414.
18. Plot L., Amital H. Infectious associations of celiac disease. Autoimmun Rev 2009, 8:316-319.
19. Fumagalli M., Sironi M., Pozzoli U., Ferrer-Admetla A., Pattini L., Nielsen R. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet 2011, 7:e1002355.
20. Lerner A. Non nutritional environmental factors associated with celiac disease: infections and vaccinations. vaccine and autoimmunity 2013, Wiley pub. Y. Shoenfeld, N. Agmon-levin (Eds.).
21. Myleus A., Hernell O., Gothefors L., Hammarström M.L., Persson L.A., Stenlund H., et al. Early infections are associated with increased risk for celiac disease: an incident case-referent study. BMC Pediatr 2012, 12:194-201.
22. Ashorn S., Valineva T., Kaukinen K., Ashorn M., Braun J., Raukola H., et al. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol 2009, 29:190-195.
23. Papp M., Foldi I., Altorjay I., Palyu E., Udvardy M., Tumpek J., et al. Anti-microbial antibodies in celiac disease: trick or treat. World J Gastroenterol 2009, 15:3891-3900.
24. Bethune M.T., Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog 2008, 4:e34.
25. Marild K., Ye W., Lebwohl B., Green P.H., Blaser M.J., Card T., et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol 2013, 13:109-117.
26. Wacklin P., Kaukinen K., Tuovinen E., Collin P., Lindfors K., Partanen J., et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 2013, 19:934-941.
27. Sanchez E., De Palma G., Capilla A., Nova E., Pozo T., Castillejo G., et al. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species. Appl Environ Microbiol 2011, 77:5316-5323.
28. Pozo-Rubio T., de Palma G., Mujico Jorge R., Olivares M., Marcos A., Acuna M.D., et al. Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; The PROFICEL study. Nutr Hosp 2013, 28:464-473.
29. Heyman M., Abed J., Lebreton C., Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 2012, 61:1355-1364.
30. Sarmiento L., Galvan Jose A., Cabrera-Rode E., Aira L., Correa C., Sariego S., et al. Type 1 diabetes associated and tissue transglutaminase autoantibodies in pateints without type 1 diabetes and celiac disease with confirmed viral infections. J Med Virol 2012, 84:1049-1053.
31. Montelone G., Pender S.L., Wathen N.C., MacDonald T.T. Interferon alfa drive T cell mediated immunopathology in the intestine. Eur J Immunol 2001, 31:2247-2255.
32. Tanpowpong P., Obuch J.C., Jiang H., McCarty C.E., Katz A.J., Leffler D.A., et al. Multicenter study on season of birth and celiac disease: evidence for a new theoretical model of pathogenesis. J Pediatr 2013, 162:501-504.
33. Marconcini Maira L., Fayad L., Shiozawa M., Beatriz C., Schiavon Ld Lucca, Narciso-Schiavon J.L. Autoantibody profile in individuals with chronic hepatitis C. Revista da Sociedade Brasilrira de, Medicina 2013, 46:147-153.
34. Gravina Antonietta G., Federico A., Masarone M., Cuomo A., Tuccillo C., Loguercio C., et al. Coeliac disease and C virus-related chronic hepatitis: a non association. BMC Res Notes 2012, 5:533-537.
35. Carlsson A.K., Lindberg B.A., Bredberg A.C., Hyoty H., Ivarsson S.A. Enterovirus infection during pregnancy is not a risk factor for celiac disease in the offspring. J Pediatr Gastroenterol Nutr 2002, 35:649-652.
36. Lawler M., Humpheries P.O., Farrelly C. Adenovirus 12 E1A gene detection by polymerase chain reaction in both normal and celiac duodenum. Gut 1994, 35:1226-1232.
37. Stene L.C., Honeyman M.C., Hoffenberg E.J., Haas J.E., Sokol R.J., Emery L., et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood:alongitudinal study. Amer J Gastroenterol 2006, 101:2333-2340.
38. Dolcino M., Zanoni G., Bason C., Tinazzi E., Boccola E., Valletta E., et al. A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84. Immunol Res 2013, 56:465-476.
39. Sabayan B., Foroughinia F., Imanieh M.H. Can Canpylobacter jejuni play a role in development of celiac disease? A hypothesis. World J Gastroenterol 2007, 13:4784-4785.
40. Riddle M.S., Murray J.A., Cash B.D., Pimentel M., Porter C.K. Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci 2013, 58:3242-3245.
41. Verdu E.F., Mauro M., Bourgeois J., Armstrong D. Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. Can J Gastroenterol 2007, 21:453-455.
42. Ludvigsson J.F., Olen O., Bell M., Ekbom A., Montgomery S.M. Coeliac disease and risk of sepsis. Gut 2008, 57:1074-1080.
43. Mohammad Rostami-Nejad, Kamran Rostami, Cheraghipour K., Nazemalhosseini Mojarad E., Volta U., Al Dulaimi D., et al. Celiac disease increases the risk of Toxoplasma gondii infection in a large cohot of pregnant women. Amer J Gastroenterol 2011, 106:548-549.
44. Ludvigsson J.F., Sanders D.S., Maeurer M., Jonsson J., Grunewald J., Wahlström J. Risk of tuberculosis in a large sample of patients with celiac disease-a nationwide cohort study. Aliment Pharmacol Ther 2011, 33:689-696.
45. Iglesias S., vazquer Rodrigues S., Ulla Rocha J.L., Baltar Arias R., Díaz Saá W., Barrio Antoranz J., et al. Onset of celiac disease after acute hepatitis B infection. Gastroenterol Hepatol 2010, 33:17-20.
46. Ouakaa-Kchaou A., Gargouri D., Kharrat J., Ghorbel A. Relationship between hepatitis B virus infection and celiac disease. Hepat Mon 2010, 10:313-314.
47. Aydogdu S., Cakir M., Yuksekkaya H.A., Tumgor G., Baran M., Arikan C., et al. Helicobacter pylori infection in children with celiac disease. Scand J Gastroenterol 2008, 43:1088-1093.
48. Rostami-Nejad M., Rostami K., Yamaoka Y., Mashayekhi R., Molaei M., Dabiri H., et al. Clinical and histological presentation of helicobacter pylori and gluten related gastroenteropathy. Arch Iran Med 2011, 14:115-118.
49. McSorly H.J., Gaze S., Daveson J., Jones D., Anderson R.P., Clouston A., et al. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One 2011, 6:e24092.
50. Sandberg-bennich S., Dahlquist G. kallen B. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr 2002, 91:30-33.
51. Marild K., Stephansson O., Montgomery S., Murray J.A., Ludvigsson J.F. Pregnancy outcome and risk of celiac disease in offspring; a nationwide case-control study. Gastroenterology 2011, 142:39-45 e33.
52. Welander A., Tjernberg A.R., Montgomery S.M., Ludvigsson J., Ludvigsson J.F. Infectious disease and risk of later celiac disease in childhood. Pediatrics 2010, 125:e530-e536.
53. Kondrashova A., Mustalahti K., Kaukinen K., Viskari H., Volodicheva V., Haapala A.M., et al. Lower economic status and inferior environment may protect against celiac disease. Ann Med 2008, 40:223-231.
54. Plot L., Amital H., Barzilai O., Ram M., Bizzaro N., Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann NY Acad Sci 2009, 1173:670-674.
55. DePaolo R.W., Abadie V., Tang F., Fehlner-Peach H., Hall J.A., Wang W., et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory innunity to dietary antigens. Nature 2011, 471(7337):220-224.
56. Rostami-Nejad M., Rostami K., Sanaei M., Mohebbi S.R., Al-Dulaimi D., Nazemalhosseini-Mojarad E., et al. Rotavirus and celiac autoimmunity among adults with non-specific gastrointestinal symptoms. Saudi Med J 2010, 31:891-894.
57. Zanoni G., Navone R., Lunardi C., Tridente G., Bason C., Sivori S., et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006, 3:e358.
58. Wang Y., Dennehy P.H., Keyserling H.I., Tang K., Gentsch J.R., Glass R.I., et al. Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol 2007, 81:3904-3912.